TP53 and cancer: Although the high rate of TP53 mutation and the complex DNA alterations have been observed in ESCC and other cancers [37–41], to our knowledge this is the first analysis on a large sample size that pinpoints the high frequency of G1 control deregulation caused by genomic alterations in ESCC.